Prescription Drug Affordability Board Activity through August 15, 2024

Colorado clarifies who their Upper Payment Limit rule applies to. Maryland picks six drugs to conduct cost reviews for and requests information from the public in an effort to produce something by year end. Oregon pauses affordability reviews for 2024 while it gathers feedback from stakeholders. Washington considers the eligibility criteria for drugs to be reviewed, looking to states like Colorado for guidance.

[...]

Prescription Drug Affordability Boards

Prescription Drug Affordability Boards States across the country are experimenting with Prescription Drug Affordability Boards (PDABs) to address the price of medicine. Each state has a different approach. Several exist to negotiate supplemental Medicaid rebates; others make recommendations to limit costs. A third group of PDABs is particularly concerning because they have the power to…

[...]

A peek inside a prescription drug diversion ring

The indictment and pre-sentencing memo from the Southern District of New York’s prosecution of Boris Aminov offer a “how-did-they-do-it” guide to prescription drug health care fraud, capturing text messages, crime photos, and a step-by-step guide to the deceit.

[...]